Navigation Links
Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
Date:3/5/2008

Full Year Revenue Up 47.3% and Net Income Up 63.5% Compared to 2006

Company Declares Cash Dividend of US$0.18 Per Share

SHENZHEN, China, March 5 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced its selected unaudited financial results for the fourth quarter and full year ended December 31, 2007.

Highlights for the Full Year 2007

-- Full year 2007 net revenues were RMB2,230.9 million (US$305.8 million),

an increase of 47.3% over the full year 2006.

-- Net revenues generated in international markets in the full year

2007 increased 53.3% to RMB1,128.0 million (US$154.6 million)

from RMB735.6 million in the full year 2006.

-- Net revenues generated in China in the full year of 2007 increased

41.5% to RMB1,102.9 million (US$151.2 million) from RMB779.4 million

in the full year 2006.

-- Full year 2007 non-GAAP net income, as defined below, was RMB672.0

million (US$92.1 million), an increase of 61.2% from RMB416.8 million

in the full year 2006. Full year GAAP net income was RMB591.6 million

(US$81.1 million), an increase of 63.5% from RMB361.8 million in the

full year 2006.

-- Full year 2007 non-GAAP diluted earnings per share, as defined below,

was RMB5.95 (US$0.82). Full year 2007 GAAP diluted earnings per share

was RMB5.23 (US$0.72).

Highlights for Fourth Quarter 2007

-- Fourth quarter 2007 net revenues were RMB673.8 million (US$92.4

million), an increase of 41.2% over the fo
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008
2. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
3. Mindray to Attend 2008 CLSA Asia Investors Forum
4. Mindray to Attend 2007 RSNA Conference in Chicago
5. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
6. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
7. Physicians Wellness Network and Home Access Health to Provide Medically Compliant Diabetes Testing Sold Directly to Consumers
8. Medical Mutual of Ohio Issues Fraud Report
9. Dental Network of America Inc. Launches Integrated Medical-Dental Health Program
10. Template-Free Electronic Medical Record Wins AAFP User Satisfaction Survey.
11. Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewsw...sdaq: SHMR ) ( "Shamir" ), a leading provider of ...ic lens market, announced today that its board of ...an aggregate amount of US$ 10 million (approximate...9 representative rate of exchange), or approximate...
(Date:11/27/2009)... Voyant Health™ anno...chigan) has licensed its TraumaCad Enterprise orth...d workflow solution. , (P...nounced today that Spectrum Health (Grand Rapids, ...thopedic templating solution and its TraumaCad Ext...
(Date:11/26/2009)..., , PRINCETON, N.J., Nov. 27 /PRNewswire/...ill almost double over the next 25 years and annua...hit $336 billion, up from $113 billion today, acco...f Diabetes Care . The National Changing Diabete..., commissioned the analysis by a team from the Uni...
(Date:11/26/2009)... No more letters from the ...,personalized text messages from Santa , ...fort to increase operational efficiencies at the N... to help keep children all over the globe informed...Elves in Santa’s research department have id...
(Date:11/25/2009)..., , EDINA, Minn., Nov. 25 /PRNewswire-USNew...hey think of their dentist. But a chiropractor ca...s for the Temporal-Mandibular Joint, which is wher...skull (temporal bone). ,, The most common symp... chewing, clicking or popping of the jaw. But man...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ACH, Calif., June 25 Function Drinks,announced to...NIGHT LIFE, a,physician,s take on supporting sexua...xtract macuna pruriens and the amino acid, tyrosin...d,cnidium help support healthy circulation. Functi...
...ati, OH, June 25, 2008--Bassinet use in 2006 was n...more than 45% of infants between the ages of 0-2 m...ety. In fact, the Consumer Product Safety Commiss...of Pediatrics (AAP) revised its recommendations fo...
...DOVA, Calif., June 24 Executive,Director, Diana F...s who,need financial assistance to help them pay f...ademic year State Nursing Assumption Program of Lo...ces to help them pay for their postsecondary educa...
...on could mean fewer shots for 4 to 6 year-olds in ...e (NYSE:,GSK) announced today that the U.S. Food a...M) [Diphtheria and Tetanus Toxoids and Acellular P...lio,diseases in one shot., "Children 4 to 6 years...
...Y, Mo., June 24 DST Systems, Inc.,(NYSE: DST ) w...uarter,ending June 30, 2008, on Tuesday, July 22, ...tock Exchange., The Company will host a conferenc...arnings Release. For international,callers, the di...
...a., June 24 Alan J. Zuccari,President & CEO of Ha...,Action Committee (PAC) member for the American He...k with the committee., "It,s an honor to be recog...are.", Below is the article which will be feature...
Other Medicine News:Health News:Function Drinks Launches New Product to Support Sexual Health 2Health News:Bedsharing and bassinets: 2 new studies assess the risks 2Health News:Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008 2Health News:FDA Approves KINRIX(TM) - New Combination Vaccine for Children 2Health News:FDA Approves KINRIX(TM) - New Combination Vaccine for Children 3Health News:DST Systems, Inc. Announces Notification of Earnings Release Date 2Health News:Alan J. Zuccari Featured by the American Health Care Association as a June PAC Member 2
(Date:11/25/2009)....C., Nov. 25 Cempra Pharmaceutical... president and chief executive officer, will prese...nference at 8:50 a.m. EST, December 1, 2009, at Th...nandes will provide an overview of the company,s t...eatment of drug-resistant pathogens including MRSA...
(Date:11/25/2009)...Netherlands and JOHANNESBURG, November 25 /PRNewsw...and Pyxis Discovery announced today,that they have...t both,companies, services. , Pyxis,s wor...y expertise,will be coupled with iThemba,s service...stry support to projects identified through Pyxis,...
(Date:11/24/2009)... Md., Nov. 24 /PRNewswire-Asia/ -- Chindex Interna...ng independent American provider of Western,health...c of China, today,announced that the Company will ...ealth Care Conference, to be held December 1 - 2, ...agement is currently scheduled to present at 11:30...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 1Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 2Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 3VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 1VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 2VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 1Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 2Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 4Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 5
...ts with multiple sclerosis, remained relapse-fre...- New data demonstrate 89% of patients free from a...S - three years after starting treatment, - MS, a...y, affects 2.5 million people worldwide i...lings planned before end of 2009 in US and EU, EA...
...sis of methotrexate,resistance and differences in ...The first analysis,of the genetic determinants of ... childhood acute lymphoblastic leukemia (ALL) coul...d treatments to overcome it,according to a St. Jud...s use in ALL, methotrexate is widely used to treat...
Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 2St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 3St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 4
...ant is a combination of innovative design, consist...y that makes BrachySource I-125 implant an ideal c...confident that every BrachySource I-125 implant or...h is required by clinicians who must meet the time...
...t is a combination of innovative design, consisten...hat makes TheraSeed® treatment an ideal choice...dent that every TheraSeed® implant order is ba...ired by clinicians who must meet the time-critical...
Double-J® II Closed Tip Ureteral Stents
Stent Positioners with Radiopaque Band
Medicine Products: